TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 234 filers reported holding TG THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $411,136 | -67.7% | 49,179 | -4.0% | 0.00% | -60.0% |
| Q2 2023 | $1,272,081 | +38.1% | 51,211 | -16.4% | 0.01% | +25.0% |
| Q1 2023 | $921,305 | -51.1% | 61,257 | -61.5% | 0.00% | -55.6% |
| Q4 2022 | $1,884,637 | +95.1% | 159,310 | -2.4% | 0.01% | +80.0% |
| Q3 2022 | $966,000 | +79.2% | 163,215 | +28.8% | 0.01% | +66.7% |
| Q2 2022 | $539,000 | +450.0% | 126,706 | +1135.0% | 0.00% | – |
| Q1 2022 | $98,000 | -66.3% | 10,260 | +36.7% | 0.00% | -100.0% |
| Q2 2021 | $291,000 | -49.9% | 7,505 | -37.7% | 0.00% | -66.7% |
| Q1 2021 | $581,000 | +157.1% | 12,050 | +3.9% | 0.00% | +200.0% |
| Q2 2020 | $226,000 | – | 11,598 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 6,880,323 | $38,633,000 | 2.30% |
| Eversept Partners, LP | 773,501 | $4,343,208 | 1.35% |
| Opaleye Management Inc. | 612,500 | $3,439,000 | 1.24% |
| BRIDGER MANAGEMENT, LLC | 2,334,196 | $13,107,000 | 1.08% |
| Sofinnova Investments, Inc. | 1,733,628 | $9,734,000 | 0.88% |
| PURA VIDA INVESTMENTS, LLC | 354,719 | $1,992,000 | 0.34% |
| 683 Capital Management, LLC | 400,000 | $2,246,000 | 0.25% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 649,460 | $3,646,000 | 0.23% |
| Artal Group S.A. | 900,000 | $5,054,000 | 0.20% |
| Frontier Wealth Management LLC | 226,750 | $1,273,000 | 0.19% |